The prognostic value of tumor budding in gastric adenocarcinomas: A cross-sectional study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Tumor budding is a negative prognostic factor for many solid malignancies. We investigated the relationship between patients’ clinico-pathological characteristics and tumor budding, as well as the effect of budding level on prognosis. Methods: In this retrospective, cross-sectional, and descriptive study at a tertiary university hospital, 104 patients with gastric adenocarcinoma were divided into two groups according to whether they had a high (≥ 10 buds) or low (< 10 buds) level of budding. The patients were retrospectively evaluated.Results: Sixty-two patients had a low level of budding and 42 had a high level of budding. The mean time from the first diagnosis to the last follow-up was significantly longer (P < 0.05) in the low-budding group (27 months) than in the high-budding group (17 months). As the T stage, N stage, grade, and size of the tumor increased, the proportion of patients with high budding was found to be significantly higher (P < 0.05). High tumor budding, an age of 60 or over at diagnosis, a low body mass index, high N stage, presence of lymphovascular invasion, and recurrence were associ-ated with overall survival.Conclusion: Our study supports that budding is a negative prognostic factor in gastric cancer.
Abstract
Background: Tumor budding is a negative prognostic factor for many solid malignancies. We investigated the relationship between patients’ clinico-pathological characteristics and tumor budding, as well as the effect of budding level on prognosis. Methods: In this retrospective, cross-sectional, and descriptive study at a tertiary university hospital, 104 patients with gastric adenocarcinoma were divided into two groups according to whether they had a high (≥ 10 buds) or low (< 10 buds) level of budding. The patients were retrospectively evaluated.Results: Sixty-two patients had a low level of budding and 42 had a high level of budding. The mean time from the first diagnosis to the last follow-up was significantly longer (P < 0.05) in the low-budding group (27 months) than in the high-budding group (17 months). As the T stage, N stage, grade, and size of the tumor increased, the proportion of patients with high budding was found to be significantly higher (P < 0.05). High tumor budding, an age of 60 or over at diagnosis, a low body mass index, high N stage, presence of lymphovascular invasion, and recurrence were associ-ated with overall survival.Conclusion: Our study supports that budding is a negative prognostic factor in gastric cancer.
참고문헌 (30)
- Bray F, "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
- Song Z, "Progress in the treatment of advanced gastric cancer", Tumour Biol, 39, pp.1010428317714626~ (2017)
- Ikoma N, "Survival rates in T1 and T2 gastric cancer : a Western report", J Surg Oncol, 114, pp.602~606 (2016)
- Yamaguchi Y, "Histopathologic features of the tumor budding in adenocarcinoma of the lung : tumor budding as an index to predict the potential aggressiveness", J Thorac Oncol, 5, pp.1361~1368 (2010)
- Imai T, "Growth patterns in human carcinoma. Their classification and relation to prognosis", Obstet Gynecol, 16, pp.296~308 (1960)
- Morodomi T, "An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer", Cancer, 63, pp.539~543 (1989)
- Ueno H, "Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer", Histopathology, 40, pp.127~132 (2002)
- Lugli A, "Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference(ITBCC)2016", Mod Pathol, 30, pp.1299~1311 (2017)
- Quirke P, "European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Quality assurance in pathology in colorectal cancer screening and diagnosis", Endoscopy, 44(Suppl 3), pp.SE116~SE130 (2012)
- Kazama S, "Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5. 2", Br J Cancer, 94, pp.293~298 (2006)
- "Strengthening the reporting of observational studies in epidemiology. What is strobe?" (2019)[URL]
- Che K, "Prognostic significance of tumor budding and single cell invasion in gastric adenocarcinoma", Onco Targets Ther, 10, pp.1039~1047 (2017)
- Tanaka K, "Tropomyosinrelated receptor kinase B at the invasive front and tumour cell dedifferentiation in gastric cancer", Br J Cancer, 110, pp.2923~2934 (2014)
- Liang F, "The prognostic value of tumor budding in invasive breast cancer", Pathol Res Pract, 209, pp.269~275 (2013)
- Koyuncuoglu M, "Tumor budding and E-Cadherin expression in endometrial carcinoma : are they prognostic factors in endometrial cancer?", Gynecol Oncol, 125, pp.208~213 (2012)
- O'Connor K, "Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma", Am J Surg Pathol, 39, pp.472~478 (2015)
- Almangush A, "Tumour budding in head and neck squamous cell carcinoma-a systematic review", Histopathology, 65, pp.587~594 (2014)
- Brown M, "Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro-oesophageal junction cancers", Histopathology, 56, pp.893~899 (2010)
- Kai K, "Tumor budding and dedifferentiation in gallbladder carcinoma : potential for the prognostic factors in T2 lesions", Virchows Arch, 459, pp.449~456 (2011)
- Guo YX, "Prognostic and pathological impact of tumor budding in gastric cancer : a systematic review and meta-analysis", World J Gastrointest Oncol, 11, pp.898~908 (2019)
- Ulase D, "Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus Conference", Histopathology, 76, pp.433~446 (2020)
- Koelzer VH, "Tumor budding in upper gastrointestinal carcinomas", Front Oncol, 4, pp.216~ (2014)
- Fang C, "Risk factors of lymph node metastasis in early gastric carcinomas diagnosed by WHO criteria in 379 Chinese patients", J Dig Dis, 17, pp.526~537 (2016)
- Gotoda T, "Incidence of lymph node metastasis from early gastric cancer : estimation with a large number of cases at two large centers", Gastric Cancer, 3, pp.219~225 (2000)
- Du M, "Tumor budding and other risk factors of lymph node metastasis in submucosal early gastric carcinoma : a multicenter clinicopathologic study in 621 radical gastrectomies of Chinese patients", Am J Surg Pathol, 43, pp.1074~1082 (2019)
- Olsen S, "Tumor budding in intestinal-type gastric adenocarcinoma is associated with nodal metastasis and recurrence", Hum Pathol, 68, pp.26~33 (2017)
- Gabbert HE, "Tumor-cell dissociation at the invasion front : a new prognostic parameter in gastric cancer patients", Int J Cancer, 50, pp.202~207 (1992)
- Kemi N, "Tumor budding and prognosis in gastric adenocarcinoma", Am J Surg Pathol, 43, pp.229~234 (2019)
- Zhang N, "The special immune microenvironment of tumor budding and its impact on prognosis in gastric adenocarcinoma", Pathol Res Pract, 216, pp.152926~ (2020)
- Grigore AD, "Tumor budding : the name is EMT. Partial EMT", J Clin Med, 5, pp.51~ (2016)